REVANCE THERAPEUTICS INC shareholders Q1 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CENTRAL TRUST Co 50$1,6110.00%
JFS WEALTH ADVISORS, LLC 3$970.00%
TORONTO DOMINION BANK 5$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 53,665$1,728,5490.00%
US BANCORP \DE\ 3,978$128,1320.00%
OSAIC HOLDINGS, INC. 3,698$119,1090.00%
Allworth Financial LP 432$13,9160.00%
BerganKDV Wealth Management, LLC 38$1,2240.00%
ROYAL BANK OF CANADA 43,813$1,411,0000.00%
Ellevest, Inc. 4$1290.00%
PRICE T ROWE ASSOCIATES INC /MD/ 42,793$1,3790.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 5$1610.00%
PRUDENTIAL FINANCIAL INC 8,963$288,6980.00%
Legal & General Group Plc 42,377$1,364,9630.00%
Daiwa Securities Group Inc. 331$110.00%
NATIONAL BANK OF CANADA /FI/ 1,040$33,4670.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Lindbrook Capital, LLC 131$4,2200.00%
Creative Planning 53$1,7080.00%
Covestor Ltd 8$00.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q1 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.